Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Frequency of benign tumors after partial nephrectomy and the association between malignant tumor findings and preoperative clinical parameters

V. Lounová, V. Študent, D. Purová, I. Hartmann, A. Vidlář, V. Študent

. 2024 ; 24 (1) : 175. [pub] 20240822

Language English Country England, Great Britain

Document type Journal Article

BACKGROUND: Partial nephrectomy (PN) has become the dominant treatment modality for cT1 renal tumor lesions. Tumors suspected of malignant potential are indicated for surgery, but some are histologically classified as benign lesions after surgery. This study aims to analyze the number of benign findings after PN according to definitive histology and to evaluate whether there is an association between malignant tumor findings and individual factors. METHODS: The retrospective study included 555 patients who underwent open or robotic-assisted PN for a tumor in our clinic from January 2013 to December 2020. The cohort was divided into groups according to definitive tumor histology (malignant tumors vs. benign lesions). The association of factors (age, sex, tumor size, R.E.N.A.L.) with the malignant potential of the tumor was further evaluated. RESULTS: In total, 462 tumors were malignant (83%) and 93 benign (17%). Of the malignant tumors, 66% were clear-cell RCC (renal cell carcinoma), 12% papillary RCC, and 6% chromophobe RCC. The most common benign tumor was oncocytoma in 10% of patients, angiomyolipoma in 2%, and papillary adenoma in 1%. In univariate analysis, there was a higher risk of malignant tumor in males (OR 2.13, 95% CI 1.36-3.36, p = 0.001), a higher risk of malignancy in tumors larger than 20 mm (OR 2.32, 95% CI 1.43-3.74, p < 0.001), and a higher risk of malignancy in tumors evaluated by R.E.N.A.L. as tumors of intermediate or high complexity (OR 2.8, 95% CI 1.76-4.47, p < 0.001). In contrast, there was no association between older age and the risk of malignant renal tumor (p = 0.878). CONCLUSIONS: In this group, 17% of tumors had benign histology. Male sex, tumor size greater than 20 mm, and intermediate or high R.E.N.A.L. complexity were statistically significant predictors of malignant tumor findings.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24019287
003      
CZ-PrNML
005      
20241024111407.0
007      
ta
008      
241015s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1186/s12894-024-01543-3 $2 doi
035    __
$a (PubMed)39174947
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Lounová, Veronika $u Department of Urology, University Hospital Olomouc Palacký University Olomouc, Olomouc, Czech Republic
245    10
$a Frequency of benign tumors after partial nephrectomy and the association between malignant tumor findings and preoperative clinical parameters / $c V. Lounová, V. Študent, D. Purová, I. Hartmann, A. Vidlář, V. Študent
520    9_
$a BACKGROUND: Partial nephrectomy (PN) has become the dominant treatment modality for cT1 renal tumor lesions. Tumors suspected of malignant potential are indicated for surgery, but some are histologically classified as benign lesions after surgery. This study aims to analyze the number of benign findings after PN according to definitive histology and to evaluate whether there is an association between malignant tumor findings and individual factors. METHODS: The retrospective study included 555 patients who underwent open or robotic-assisted PN for a tumor in our clinic from January 2013 to December 2020. The cohort was divided into groups according to definitive tumor histology (malignant tumors vs. benign lesions). The association of factors (age, sex, tumor size, R.E.N.A.L.) with the malignant potential of the tumor was further evaluated. RESULTS: In total, 462 tumors were malignant (83%) and 93 benign (17%). Of the malignant tumors, 66% were clear-cell RCC (renal cell carcinoma), 12% papillary RCC, and 6% chromophobe RCC. The most common benign tumor was oncocytoma in 10% of patients, angiomyolipoma in 2%, and papillary adenoma in 1%. In univariate analysis, there was a higher risk of malignant tumor in males (OR 2.13, 95% CI 1.36-3.36, p = 0.001), a higher risk of malignancy in tumors larger than 20 mm (OR 2.32, 95% CI 1.43-3.74, p < 0.001), and a higher risk of malignancy in tumors evaluated by R.E.N.A.L. as tumors of intermediate or high complexity (OR 2.8, 95% CI 1.76-4.47, p < 0.001). In contrast, there was no association between older age and the risk of malignant renal tumor (p = 0.878). CONCLUSIONS: In this group, 17% of tumors had benign histology. Male sex, tumor size greater than 20 mm, and intermediate or high R.E.N.A.L. complexity were statistically significant predictors of malignant tumor findings.
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    12
$a nádory ledvin $x chirurgie $x patologie $7 D007680
650    _2
$a ženské pohlaví $7 D005260
650    12
$a nefrektomie $x metody $7 D009392
650    _2
$a lidé středního věku $7 D008875
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a senioři $7 D000368
650    _2
$a karcinom z renálních buněk $x chirurgie $x patologie $x epidemiologie $7 D002292
650    _2
$a angiomyolipom $x patologie $x chirurgie $7 D018207
650    _2
$a dospělí $7 D000328
650    _2
$a předoperační období $7 D057234
650    _2
$a oxyfilní adenom $x patologie $x chirurgie $7 D018249
655    _2
$a časopisecké články $7 D016428
700    1_
$a Študent, Vladimír $u Department of Urology, University Hospital Olomouc Palacký University Olomouc, Olomouc, Czech Republic. vladastudent@gmail.com
700    1_
$a Purová, Dana $u Olomouc University Social Health Institute, Palacky University Olomouc, Olomouc, Czech Republic
700    1_
$a Hartmann, Igor $u Department of Urology, University Hospital Olomouc Palacký University Olomouc, Olomouc, Czech Republic
700    1_
$a Vidlář, Aleš $u Department of Urology, University Hospital Olomouc Palacký University Olomouc, Olomouc, Czech Republic
700    1_
$a Študent, Vladimír $u Department of Urology, University Hospital Olomouc Palacký University Olomouc, Olomouc, Czech Republic
773    0_
$w MED00008208 $t BMC urology $x 1471-2490 $g Roč. 24, č. 1 (2024), s. 175
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39174947 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241015 $b ABA008
991    __
$a 20241024111401 $b ABA008
999    __
$a ok $b bmc $g 2201868 $s 1231260
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 24 $c 1 $d 175 $e 20240822 $i 1471-2490 $m BMC urology $n BMC Urol $x MED00008208
LZP    __
$a Pubmed-20241015

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...